NewAmsterdam Pharma (NAMS) Cash & Current Investments (2021 - 2026)
NewAmsterdam Pharma (NAMS) reported Cash & Current Investments of $633.85 million for Q2 2026, down 14.2% from $739.16 million a year earlier and down 0.4% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Cash & Current Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, NewAmsterdam Pharma posted Cash & Current Investments of $636.24 million, down 23.7% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of 134.5% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $834.19 million in FY2024 (+145.0%), $340.45 million in FY2023 (-26.3%), $462.18 million in FY2022 (+635.6%) and $62.83 million in FY2021 (+600.0%).
- The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q3 2024.
- Year over year, Cash & Current Investments has now declined in each of the last three quarters, with growth averaging 38.3% over the last eight quarters.
- The high point for year-over-year Cash & Current Investments in five years was Q4 2022 (growth of 636.6%); the low point was Q4 2023 (a decline of 23.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $636.11 million (Q1 2026), $636.24 million (Q4 2025) and $702.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | NewAmsterdam Pharma | 2.32 Bn | -290.23 Mn | - | 633.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 633.85 Mn |
| Mar 31, 2026 | 636.11 Mn |
| Dec 31, 2025 | 636.24 Mn |
| Sep 30, 2025 | 702.95 Mn |
| Jun 30, 2025 | 739.16 Mn |
| Mar 31, 2025 | 808.48 Mn |
| Dec 31, 2024 | 834.19 Mn |
| Sep 30, 2024 | 422.73 Mn |
| Jun 30, 2024 | 430.71 Mn |
| Mar 31, 2024 | 481.15 Mn |
| Dec 31, 2023 | 340.45 Mn |
| Sep 30, 2023 | 368.31 Mn |
| Jun 30, 2023 | 416.78 Mn |
| Mar 31, 2023 | 441.31 Mn |
| Dec 31, 2022 | 467.50 Mn |
| Jun 30, 2022 | 93.47 Mn |
| Dec 31, 2021 | 60.13 Mn |
API Access
NewAmsterdam Pharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();